No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

AI-LAB Federated Learning: A Leap Forward for Radiology AI Development

Editor: What To Know

  • The AI-LAB process empowers radiologists to participate in AI creation, evaluation and validation, and meet coming responsibilities, requirements and opportunities in a future where AI will increasingly be used in daily practice.
  • These sites will have access to both the community-created models and anonymized performance benchmarks so that they can understand performance of the algorithm produced by the greater clinical community to one that is fine-tuned to their own site's data.
  • “Radiologists must prepare to serve as the imaging AI experts, gatekeepers of which AI technologies are purchased by their practices, and monitors of AI performance in patient care,” Keith J.

AI-LAB Federated Learning: Radiologists can now register their practices to take part in the next-generation American College of Radiology Data Science Institute® artificial intelligence (AI) federated learning program hosted on the AI-LAB™ platform.

With AI-Lab federated learning, registered sites soon can participate in multi-site algorithm creation while allowing their data to remain safely on their own servers.

These sites will have access to both the community-created models and anonymized performance benchmarks so that they can understand performance of the algorithm produced by the greater clinical community to one that is fine-tuned to their own site’s data. This process will help them tune their own AI implementations to meet clinical needs.

“We as radiologists must take advantage of the new AI-LAB capabilities and leverage emerging opportunities to provide better patient care,” said Bibb Allen, MD, FACR, ACR Data Science Institute Chief Medical Officer. “The AI-LAB can allow radiologists to access resources to help them develop skills necessary to practice integrated diagnostics, become better physicians, and enhance the value we bring to patients and health systems.”

The AI-LAB process empowers radiologists to participate in AI creation, evaluation and validation, and meet coming responsibilities, requirements and opportunities in a future where AI will increasingly be used in daily practice.

“Radiologists must prepare to serve as the imaging AI experts, gatekeepers of which AI technologies are purchased by their practices, and monitors of AI performance in patient care,” Keith J. Dreyer, DO, PhD, FACR, ACR Data Science Institute Chief Science Officer. “Not doing so is to risk patient safety and algorithm effectiveness. The new AI-LAB™ can help radiologists prepare for tomorrow’s reality.”

Get more information on taking part in AI-LAB™ federated learning.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy